Upotreba periferno uvedenoga centralnog venskog katetera (PICC) u bolesnika sa zloćudnim hematološkim bolestima - prikaz vlastitih iskustava

Scientific paper - Original scientific paper

• Title (english): The use of peripherally inserted central catheter (PICC) in patients with hematological malignancies - a single center experience
• Author: Zdravko Mitrović
• Author: Igor Komljenović
• Author: Ozren Jakšić
• Author: Željko Prka
• Author: Sandra Šestan Crnek
• Author: Radmila Ajduković Stojsavljević
• Author: Mario Piršić
• Author: Višnja Hariš
• Author: Rajko Kušec
• Author: Diana Dautović
• Author: Vlatko Pejša
• Author's institution: University of Zagreb; School of Medicine
• Scientific / art field, discipline and subdiscipline: BIOMEDICINE AND HEALTHCARE; Clinical Medical Sciences

Abstract (english)

AIM. In this study we presented our experience with peripherally inserted central venous catheter (PICC) in patients with hematological malignancies. ----- METHODS

In the period from 2009 to 2012, a total of 105 PICCs were inserted in 90 patients. Patients with Non-Hodgkin lymphoma treated with DA-EPOCH comprised almost 40% of the cohort. ----- RESULTS

The total PICC in-dwell time was 14781 days with a median of 129 days (range 8-570 days). Malposition of the PICC occurred in 12 patients (11.4%) with a successful reposition or re-insertion. In 39 patients (37%) PICC was removed before the end of treatment due to suspected or proven infection (30 patients, 29%; 2.03 per 1000 PICC days), thrombosis associated with PICC in four patients (3.8%), occlusion of the PICC (two patients), misplaced catheter (two patients), and suspected thromboembolism in a single patient. ----- CONCLUSION

PICC is a safe and convenient long-term venous access in patients with hematological malignancies.

Abstract (croatian)

Cilj. Prikazati vlastita iskustva s upotrebom periferno uvedenoga centralnog venskog katetera (PICC) u bolesnika sa zloćudnim hematološkim bolestima. ----- Metode. U razdoblju od 2009. do 2012. godine postavljeno je ukupno 105 PICC-ova kod 90 bolesnika. Bolesnici s ne-Hodgkinovim limfomima na terapiji DA-EPOCH-om čine gotovo 40% svih bolesnika. ----- Rezultati. Ukupan broj dana s PICC-om je 14.781, a medijan vremena s PICC-om je 129 dana (raspon 8 – 570 dana). Malpozicija PICC-a zabilježena je u 12 bolesnika (11,4%) i u svim slučajevima PICC je uspješno reponiran ili ponovo postavljen. Kod 39 bolesnika (37%) PICC je izvađen prije završetka liječenja: zbog sumnje na infekciju ili dokazane infekcije kod 30 bolesnika (29%; 2,03 na 1000 dana s PICC-om), tromboze vezane uz PICC kod četiri bolesnika (3,8%); okluzija lumena PICC-a kod dva bolesnika, slučajno izvučeni kateteri kod dva bolesnika te sumnja na tromboemboliju kod jedne bolesnice. ----- Zaključak. PICC je siguran i praktičan dugotrajni venski put kod bolesnika sa zloćudnim hematološkim bolestima.

• Keywords (english): Adult; Antineoplastic Combined Chemotherapy Protocols / therapeutic use; Catheterization, Central Venous / methods; Catheters, Indwelling; Critical Illness / therapy; Croatia; Female; Hematologic Neoplasms / drug therapy; Humans; Lymphoma, Non-Hodgkin / therapy; Male; Middle Aged; Thromboembolism / therapy; Treatment Outcome
• Language: croatian
• Publication type: Scientific paper - Original scientific paper
• Publication status: Published
• Peer review: Peer review
• Publication version: Published version
• Journal title: Liječnički vjesnik
• Numbering: vol. 136, no. 5-6, pp. 136-140
• p-ISSN: 0024-3477
• URN:NBN: urn:nbn:hr:105:932014
• Publication: 2014-05
• Document URL: http://lijecnicki-vjesnik.hlz.hr/lijecnicki-vjesnik/upotreba-periferno-uvedenoga-centralnog-venskog-katetera-picc-u-bolesnika-sa-zlocudnim-hematoloskim-bolestima-prikaz-vlastitih-iskustava/
• Type of resource: Text
• Access conditions: Open access
• Created on: 2024-03-28 08:01:23